Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026)
Damora Therapeutics (DMRA) posted Prepaid Assets of $410000.0 for Q1 2026, down 28.94% on a QoQ basis from $577000.0 in Q4 2025, and up 215.38% year-over-year from $130000.0 in Q1 2025.
Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026) Analysis & Trends
Damora Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $410000.0 for Q1 2026.
- Quarterly Prepaid Assets rose 215.38% year-over-year to $410000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $410000.0 (up 215.38% YoY) and the FY2025 annual result came in at $577000.0, up 541.11% from the prior year.
- Prepaid Assets was $410000.0 for Q1 2026 at Damora Therapeutics, down from $577000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.9 million in Q1 2023 and bottomed at $52000.0 in Q4 2022.
- A 5-year average of $938352.9 and a median of $339000.0 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets slumped 95.6% — and 2023, when it surged 1446.22%.
- Damora Therapeutics' Prepaid Assets stood at $52000.0 in 2022, then surged by 63.46% to $85000.0 in 2023, then grew by 5.88% to $90000.0 in 2024, then surged by 541.11% to $577000.0 in 2025, then fell by 28.94% to $410000.0 in 2026.
- Business Quant data shows DMRA's Prepaid Assets at $410000.0 in Q1 2026, $577000.0 in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 410,000.00 |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 534,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 251,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 4.86 Mn |
| Jun 30, 2021 | 246,000.00 |